Medigene AG

4 clinical trials · Sponsor

Record	Firm	Date
EPITOME-1015-I: a Study to Investigate the Safety and Tolerability of MDG1015 in Patients with Epithelial Ovarian Cancer, Gastroesophageal Adenocarcinoma, Round Cell Liposarcoma And/or Synovial Sarcoma (NCT06748872)	Medigene AG	2025-07-01
HA-1H TCR T Cell for Relapsed/Persistent Hematologic Malignancies After Allogeneic Stem Cell Transplantation (NCT04464889)	Medigene AG	2020-07-02
TCR Modified T Cells MDG1011 in High Risk Myeloid and Lymphoid Neoplasms (NCT03503968)	Medigene AG	2018-03-27

Every clearance here is in the API, with alerts when new ones post.